HURRICANE CAPITAL ADVISORS LLC’s Zevra Therapeutics ZVRA Stock Holding History

HURRICANE CAPITAL ADVISORS LLC’s Portfolio ZVRA Stock Details ZVRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$198K	Buy	+13,779	New	+$153K	0.05%	360

Other funds holding ZVRA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

HURRICANE CAPITAL ADVISORS LLC's ZVRA Position: Q2 2026 in Review

HURRICANE CAPITAL ADVISORS LLC opened a new position in Zevra Therapeutics (ZVRA) in Q2 2026: 13,779 shares worth $198K. The stake represents 0.05% of the portfolio and ranks #360 among its holdings.

159 funds tracked by Wall St. Rank hold ZVRA as of Q2 2026.

HURRICANE CAPITAL ADVISORS LLC held 13,779 shares of Zevra Therapeutics worth $198K as of Q2 2026.
Zevra Therapeutics was a new HURRICANE CAPITAL ADVISORS LLC position in Q2 2026.
Zevra Therapeutics made up 0.05% of HURRICANE CAPITAL ADVISORS LLC's portfolio in Q2 2026, its #360 holding.
159 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q2 2026.

Based on HURRICANE CAPITAL ADVISORS LLC's 13F filing for Q2 2026, filed 3 Nov 2026.